Caricamento...
The role of Asprosin in patients with dilated cardiomyopathy
BACKGROUND: Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therape...
Salvato in:
| Pubblicato in: | BMC Cardiovasc Disord |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7487662/ https://ncbi.nlm.nih.gov/pubmed/32894050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-020-01680-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|